Total Payments
$3,373
2023 Payments
$916.30
Companies
13
Transactions
26
Medicare Patients
3,224
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$2,401 (71.2%)
Other$900.00 (26.7%)
Gifts$72.00 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,401 | 24 | 71.2% |
| Honoraria | $900.00 | 1 | 26.7% |
| Gift | $72.00 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GT Medical Technologies, Inc | $972.00 | 2 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $489.17 | 4 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $360.98 | 6 | $0 (2021) |
| Biocompatibles, Inc. | $340.36 | 2 | $0 (2017) |
| Genentech USA, Inc. | $235.97 | 2 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $231.74 | 2 | $0 (2019) |
| Augmenix, Inc. | $144.95 | 1 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $124.49 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $124.22 | 2 | $0 (2018) |
| Progenics Pharmaceuticals, Inc. | $115.02 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $916.30 | 2 | GT Medical Technologies, Inc ($900.00) |
| 2022 | $115.02 | 1 | Progenics Pharmaceuticals, Inc. ($115.02) |
| 2021 | $248.26 | 2 | BOSTON SCIENTIFIC CORPORATION ($124.49) |
| 2020 | $72.00 | 1 | GT Medical Technologies, Inc ($72.00) |
| 2019 | $593.61 | 7 | Genentech USA, Inc. ($235.97) |
| 2018 | $849.60 | 8 | Janssen Scientific Affairs, LLC ($248.81) |
| 2017 | $578.32 | 5 | Biocompatibles, Inc. ($340.36) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2023 | GT Medical Technologies, Inc | GAMMATILE (Device) | Honoraria | Cash or cash equivalent | $900.00 | General |
| Category: KXK | ||||||
| 03/09/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Oncology | ||||||
| 06/30/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $115.02 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/30/2021 | BOSTON SCIENTIFIC CORPORATION | THERASPHERE (Device) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/10/2021 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $123.77 | General |
| Category: Oncology | ||||||
| 03/19/2020 | GT Medical Technologies, Inc | GammaTile (Device) | Gift | Cash or cash equivalent | $72.00 | General |
| Category: KXK | ||||||
| 10/17/2019 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $116.94 | General |
| Category: Oncology | ||||||
| 07/29/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $115.59 | General |
| Category: BioOncology | ||||||
| 07/18/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $118.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/10/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Oncology | ||||||
| 03/25/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $120.38 | General |
| Category: BioOncology/Immunology | ||||||
| 01/28/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $107.88 | General |
| Category: Oncology | ||||||
| 01/28/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Oncology | ||||||
| 10/22/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: Oncology | ||||||
| 10/08/2018 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $124.07 | General |
| Category: Oncology | ||||||
| 09/10/2018 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $105.99 | General |
| Category: Oncology | ||||||
| 07/19/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $113.71 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/16/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $111.92 | General |
| Category: Oncology | ||||||
| 04/09/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $117.86 | General |
| Category: Oncology | ||||||
| 03/29/2018 | Janssen Scientific Affairs, LLC | Erleada (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Oncology | ||||||
| 03/12/2018 | Augmenix, Inc. | SpaceOAR (Device) | Food and Beverage | In-kind items and services | $144.95 | General |
| Category: Oncology | ||||||
| 10/26/2017 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $212.87 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 10/03/2017 | Janssen Scientific Affairs, LLC | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $123.42 | General |
| Category: Oncology | ||||||
| 09/14/2017 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $127.49 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
| 04/25/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 620 | 1,542 | $2.3M | $306,622 |
| 2022 | 22 | 792 | 1,895 | $2.5M | $381,640 |
| 2021 | 24 | 834 | 1,560 | $2.2M | $444,639 |
| 2020 | 25 | 978 | 2,373 | $3.1M | $527,737 |
Total Patients
3,224
Total Services
7,370
Medicare Billing
$1.7M
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 94 | 386 | $989,628 | $100,155 | 10.1% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2023 | 24 | 31 | $398,462 | $59,060 | 14.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 127 | 484 | $287,980 | $43,306 | 15.0% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 18 | 18 | $110,724 | $24,167 | 21.8% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 32 | 97 | $59,849 | $16,576 | 27.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 55 | 86 | $87,886 | $12,623 | 14.4% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 40 | 99 | $67,290 | $9,090 | 13.5% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 17 | 41 | $21,689 | $6,987 | 32.2% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 18 | 18 | $44,596 | $6,244 | 14.0% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 37 | 40 | $37,784 | $4,951 | 13.1% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 15 | 15 | $22,650 | $4,934 | 21.8% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 28 | 87 | $28,878 | $4,296 | 14.9% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 11 | 12 | $50,964 | $4,287 | 8.4% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 48 | 67 | $22,362 | $4,147 | 18.5% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 13 | 13 | $8,203 | $2,566 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 29 | $5,892 | $1,779 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $5,655 | $1,453 | 25.7% |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2022 | 80 | 411 | $1.1M | $110,982 | 10.5% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2022 | 38 | 40 | $354,090 | $76,863 | 21.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 110 | 512 | $304,640 | $46,709 | 15.3% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 23 | 23 | $134,607 | $31,395 | 23.3% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2022 | 30 | 108 | $66,636 | $19,069 | 28.6% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 54 | 101 | $104,018 | $14,944 | 14.4% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2022 | 25 | 60 | $31,740 | $10,647 | 33.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2022 | 23 | 23 | $51,109 | $7,989 | 15.6% |
About Dr. Elizabeth Levick, MD
Dr. Elizabeth Levick, MD is a Radiation Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851385249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Levick, MD has received a total of $3,373 in payments from pharmaceutical and medical device companies, with $916.30 received in 2023. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,401).
As a Medicare-enrolled provider, Levick has provided services to 3,224 Medicare beneficiaries, totaling 7,370 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology, Radiation Oncology
- Location Cincinnati, OH
- Active Since 08/31/2005
- Last Updated 04/19/2021
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1851385249
Products in Payments
- GAMMATILE (Device) $900.00
- Erleada (Drug) $365.75
- THERASPHERE - BIO (Device) $340.36
- Xofigo (Drug) $250.84
- PROVENGE (Drug) $231.74
- SpaceOAR (Device) $144.95
- THERASPHERE (Device) $124.49
- IMFINZI (Drug) $124.22
- ZYTIGA (Drug) $123.42
- Rituxan (Biological) $120.38
- TECENTRIQ (Biological) $115.59
- PYLARIFY (Drug) $115.02
- Rubraca (Drug) $111.92
- Vitrakvi (Drug) $110.14
- Onivyde (Drug) $105.99
- GammaTile (Device) $72.00
- Lenvima (Drug) $16.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Cincinnati
John Breneman, Md, MD
Radiation Oncology — Payments: $6,514
Radiation Oncology $6,514
Dr. Matthew Bertke, M.d, M.D
Radiation Oncology — Payments: $5,019
Radiation Oncology $5,019
Emily Daugherty, Md, MD
Radiation Oncology — Payments: $2,311
Radiation Oncology $2,311
Dr. Christopher Freese, M.d, M.D
Radiation Oncology — Payments: $2,052
Radiation Oncology $2,052
David Long, Md, MD
Radiation Oncology — Payments: $1,856
Radiation Oncology $1,856
Dr. Michael Shehata, M.d, M.D
Radiation Oncology — Payments: $1,268
Radiation Oncology $1,268